The roles of hypermethylation and demethylation of suppressor of cytokine signaling 1 gene in typical myelo-proliferative neoplasms
QIN Wei,LU Hui-na,HUANG Bin-bin,XIU Bing,BO Lan-jun,GAO Qing-mei,ZHANG Wen-jun,LIANG Ai-bin
DOI: https://doi.org/10.3781/j.issn.1000-7431.2011.08.009
2011-01-01
Tumori
Abstract:Objective: To investigate the clinical significance of suppressor of cytokine signaling 1 (SOCS1) hypermethylation in typical myelo-proliferative neoplasms (MPNs), and to discuss the potential mechanism. Methods: Methylation specific PCR was used to detect the hypermethylation status of SOCS1 gene in bone marrow specimens from patients with typical MPNs. Granulocyte colony stimulating factor (G-CSF) was used as a chemical inducer to simulate the MPNs cells for different time, then the real-time quantitative PCR and Western blotting were applied to evaluate the expressions of SOCS1 mRNA and protein, respectively. After the demethylating agent 2-deoxyazacytidin was used to cultivate MPNs cells for different time, SOCS1 mRNA expression was detected by real-time quantitative PCR. Results: Hypermethylation of SOCS1 was detected in 27 of 100 (27.0%) cases of MPNs. The expressions of SOCS1 mRNA in the MPNs cells were significantly decreased after G-CSF intervention in the SOCS1 hypermethylation groups as compared with those in the non-methylation groups (P0.05). The expressions of SOCS1 protein in the SOCS1 hypermethylation groups from patients with MPNs were decreased, but there was no statistically significant difference as compared with normal controls (P0.05). In addition, SOCS1 mRNA expression was markedly promoted in MPNs cells after treatment with the demethylating agent as compared with the hypermethylated groups induced by G-CSF The roles of hypermethylation and demethylation of suppressor of cytokine signaling 1 gene in typical myelo-proliferative neoplasms QIN Wei, LU Hui-na, HUANG Bin-bin, XIU Bing, BO Lan-jun, GAO Qing-mei, ZHANG Wen-jun, LIANG Ai-bin Department of Hematology, Tongji Hospital, Tongji University, Shanghai 200065, China Abstract Objective: To investigate the clinical significance of suppressor of cytokine signaling 1 (SOCS1) hypermethylation in typical myelo-proliferative neoplasms (MPNs), and to discuss the potential mechanism. Methods: Methylation specific PCR was used to detect the hypermethylation status of SOCS1 gene in bone marrow specimens from patients with typical MPNs. Granulocyte colony stimulating factor (G-CSF) was used as a chemical inducer to simulate the MPNs cells for different time, then the real-time quantitative PCR and Western blotting were applied to evaluate the expressions of SOCS1 mRNA and protein, respectively. After the demethylating agent 2-deoxyazacytidin was used to cultivate MPNs cells for different time, SOCS1 mRNA expression was detected by real-time quantitative PCR. Results: Hypermethylation of SOCS1 was detected in 27 of 100 (27.0%) cases of MPNs. The expressions of SOCS1 mRNA in the MPNs cells were significantly decreased after G-CSF intervention in the SOCS1 hypermethylation groups as compared with those in the non-methylation groups (P0.05). The expressions of SOCS1 protein in the SOCS1 hypermethylation groups from patients with MPNs were decreased, but there was no statistically significant difference as compared with normal controls (P0.05). In addition, SOCS1 mRNA expression was markedly promoted in MPNs cells after treatment with the demethylating agent as compared with the hypermethylated groups induced by G-CSF (P0.05). Conclusion: Hypermethylation of SOCS1 exists in MPNs, and the hypermethylation of CpG can inhibit the expression of SOCS1 gene. After demethylation, the expression of SOCS1 gene increases in MPNs. These suggest that the SOCS1 hypermethylation may be associated with the risk of MPNs. Demethylation may become a potential therapeutic strategy for MPNs.